90 related articles for article (PubMed ID: 16114987)
21. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
[TBL] [Abstract][Full Text] [Related]
22. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
Crankshaw CL; Marmion M; Luker GD; Rao V; Dahlheimer J; Burleigh BD; Webb E; Deutsch KF; Piwnica-Worms D
J Nucl Med; 1998 Jan; 39(1):77-86. PubMed ID: 9443741
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model.
Gambini JP; Cabral P; Alonso O; Savio E; Figueroa SD; Zhang X; Ma L; Deutscher SL; Quinn TP
Nucl Med Biol; 2011 Feb; 38(2):255-60. PubMed ID: 21315281
[TBL] [Abstract][Full Text] [Related]
24. A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG.
Cheng D; Rusckowski M; Wang Y; Liu Y; Liu G; Liu X; Hnatowich D
Curr Radiopharm; 2011 Jan; 4(1):5-9. PubMed ID: 22191610
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
Zhang XM; Zhang ZW; Wu H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
[TBL] [Abstract][Full Text] [Related]
26. Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitro.
Ballinger JR; Cowan DS; Boxen I; Zhang ZM; Rauth AM
J Nucl Med; 1993 Feb; 34(2):242-5. PubMed ID: 8381475
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line.
Lorke DE; Krüger M; Buchert R; Bohuslavizki KH; Clausen M; Schumacher U
J Nucl Med; 2001 Apr; 42(4):646-54. PubMed ID: 11337555
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer].
Shi D; Huang G; Miao J; Lin X
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):824-7. PubMed ID: 12126530
[TBL] [Abstract][Full Text] [Related]
29. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.
Okada DR; Liu Z; Johnson G; Beju D; Khaw BA; Okada RD
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1909-17. PubMed ID: 20652807
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models.
Ballinger JR; Hsue V; Rauth AM
Nucl Med Commun; 2003 May; 24(5):597-606. PubMed ID: 12717079
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.
Kabasakal L; Ozker K; Hayward M; Akansel G; Griffith O; Isitman AT; Hellman R; Collier D
Eur J Nucl Med; 1996 May; 23(5):568-70. PubMed ID: 8698063
[TBL] [Abstract][Full Text] [Related]
33. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
[TBL] [Abstract][Full Text] [Related]
34. Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937.
Perek N; Sabido O; Le Jeune N; Prevot N; Vergnon JM; Clotagatide A; Dubois F
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1290-8. PubMed ID: 18338166
[TBL] [Abstract][Full Text] [Related]
35. Localization of technetium-99m-glucarate in zones of acute cerebral injury.
Yaoita H; Uehara T; Brownell AL; Rabito CA; Ahmad M; Khaw BA; Fischman AJ; Strauss HW
J Nucl Med; 1991 Feb; 32(2):272-8. PubMed ID: 1704054
[TBL] [Abstract][Full Text] [Related]
36. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
Hendrikse NH; Franssen EJ; van der Graaf WT; Meijer C; Piers DA; Vaalburg W; de Vries EG
Br J Cancer; 1998; 77(3):353-8. PubMed ID: 9472628
[TBL] [Abstract][Full Text] [Related]
38. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.
Kinuya S; Bai J; Shiba K; Yokoyama K; Mori H; Fukuoka M; Watanabe N; Shuke N; Michigishi T; Tonami N
Ann Nucl Med; 2006 Jan; 20(1):29-34. PubMed ID: 16485571
[TBL] [Abstract][Full Text] [Related]
39. In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein.
Hendrikse NH; Kuipers F; Meijer C; Havinga R; Bijleveld CM; van der Graaf WT; Vaalburg W; de Vries EG
Cancer Chemother Pharmacol; 2004 Aug; 54(2):131-8. PubMed ID: 15118837
[TBL] [Abstract][Full Text] [Related]
40. Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake.
Alexiou GA; Goussia A; Kyritsis AP; Tsiouris S; Ntoulia A; Malamou-Mitsi V; Voulgaris S; Fotopoulos AD
Mol Imaging Biol; 2011 Apr; 13(2):348-51. PubMed ID: 20552283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
